HIMS Stock Tumbles: Here's Why It's a Buy Right Now [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
I was even more delighted when HIMS announced that they would be joining the GLP-1 trend, by offering the drug through its platform. GLP-1 Drug Mega-Trend GLP-1 drugs for obesity and weight loss, which have shown to be extremely effective, are currently one of the most profitable and exciting trends in the market today. The market has been dominated by pharmaceutical giants Eli Lilly LLY ) and Novo Nordisk NVO ). However, I see significant opportunities for less mature companies like Hims & Hers Health to get involved. While HIMS had been a strong performing stock this year, even before the GLP-1 announcement, this news is significant for the startup. The market for GLP-1 is expected to grow at a CAGR of 19.2% through 2029 and may reach a market size of $109 billion. Hims & Hers Health (HIMS) already boasts a Zacks Rank #1 (Strong Buy) rating, reflecting the significant upward revisions to its earnings. However, if the company can capture even a portion of this market, sales a
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Stock Drops 12.8% After Short Report [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Jefferies Financial Group Inc. from $14.00 to $23.00. They now have a "hold" rating on the stock.MarketBeat
- The War Over Cheaper Ozempic Won't End Well for Some Investors [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health, Inc. (HIMS) Flat As Market Sinks: What You Should Know [Yahoo! Finance]Yahoo! Finance
- Alcon (ALC) Achieves FDA 510(k) Clearance for Unity VCS and Unity CS [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 5/6/24 - Beat
HIMS
Sec Filings
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- 6/25/24 - Form 4
- HIMS's page on the SEC website